To dismiss as senseless any approach to multiple sclerosis (MS) cognitive rehabilitation given current levels of evidence would be to embrace the null, and no good scientist would do that. However, toward promoting a science of cognitive rehabilitation research in MS, this discussion will highlight the following: (a) weaknesses of functional training, (b) benefits/relative advantages of strategy training, and finally, (c) recommendations for a science-based model of rehabilitation research that incorporates both. The distinction between functional and strategy training should first be clarified, with particular attention to important areas of overlap. The key distinction can be conceptualized as restoration versus compensation: whereas functional training aims to restore cognitive function through neural-level change (e.g. remyelination, promoting neural plasticity), strategy training supports the implementation of compensatory strategies to improve functional (behavioral) outcomes, which may or may not be accompanied by observable neural-level change. As a useful analogy, consider two approaches to treating a sprained ankle: a functional approach is to incorporate a program of exercises to strengthen/repair torn ligaments in order to restore function, whereas a strategy approach is to provide the patient with a walking stick and teach her when/ how to use it in order to compensate for lost range of motion. This analogy is particularly useful as it reinforces the point that employing both strategies may be our best bet for success, although the timing of introducing respective approaches plays a key role. With regard to cognitive rehabilitation, timing is also key: functional strategies will theoretically only be successful if implemented while mechanisms of neuroplasticity are available/intact. Strategy training, however, can be implemented any time, a compelling argument for investing in this approach. Moreover, the entire impetus for functional training rests on a fundamental unknown: that lost function can be restored. As such, a science of cognitive rehabilitation needs to clearly delineate the limits of potential restoration. Strategy training, in contrast, is based on (and justified by) observable improvements in functional outcomes that result from incorporating environmental, internal, or external strategies and does not rely on evidence of restoration.
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Functional training must therefore yield two levels of evidence: (a) neural-level evidence to indicate restoration of function and (b) behavioral evidence to indicate that transfer of training has taken place. Transfer of training (i.e. the ability to show that benefits of a trained task transfer to another, untrained, task) is a topic of great debate in the brain training literature, which has yet to provide compelling evidence of its existence. 1, 2 Strategy training, however, takes a pragmatic approach: providing assistive "devices" to accommodate specific cognitive deficits, which require no transfer of training. One very powerful example of an effective cognitive strategy for persons with MS is retrieval practice, that is, the "testing effect." 3, 4 This memory technique, also effective in healthy adults 5 and other clinical populations, 6 is based on evidence showing that information we have been tested on is better remembered than information which has been repeatedly studied. Use of the strategy allows persons with MS to better remember everyday information after quizzing themselves on it when it is first encountered. A major limitation of strategy use is that its benefits are predicated entirely on just that: "use." As with medications, a cane, or swimming, the benefits of cognitive strategies are only realized if people use them. And cognitive strategies target very specific deficits: the testing effect ameliorates declarative learning, but it does not improve word-finding problems or help one remember to stop at the store on the way home. A comprehensive toolbox of strategies must be developed to address different types of deficits for people with MS, which, admittedly, may be challenging to employ among persons with cognitive impairment.
Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach -YES

VM Leavitt
Expectations for cognitive treatments may be unrealistic if our goal is to produce behavioral changes that endure beyond the intervention, as is often the objective. 7 Currently, the best available pharmacologic symptomatic treatments for MS only benefit patients during treatment administration; for example, dalfampridine (Ampyra) effectively increases walking speed but benefits immediately recede when treatment is discontinued. 8 Similarly, the most recent Cochrane review of memory interventions in MS found limited evidence of modest improvements, but most were not sustained over time. 9 In practical terms, once effective functional strategies for cognition are identified, treatment will likely need to be continuously administered to realize, retain, and reinforce benefits. Making long-term accommodations to incorporate functional strategies into everyday life will require practice, patience, diligence, and dedication.
Academic debate over the relative merits of behavioral approaches to cognitive remediation is invigorating, but there are real-world consequences to promoting and investing in ineffective cognitive treatments, consequences which are borne largely by MS patients themselves. Behavioral treatments require a substantial investment of time and effort on the part of patients, who also invest a great deal of hope. The absence of "serious" side effects/safety issues (i.e. those associated with pharmacologic treatments) does not justify reduced rigor in establishing efficacy of behavioral treatments. Randomized control trials (RCTs) of behavioral treatments for cognition should be required to adhere to the same standards as those required by drug studies, including identifying specific and scientifically justified outcomes. When neural-level outcomes are used, they must first be validated. Evidence of efficacy should be demonstrated on multiple levels. 10 An oversight board akin to the U.S. Food and Drug Administration (FDA) and an approval process such as that required for drugs should be instituted for behavioral treatments to ensure adequate rigor and efficacy.
There is great need and great momentum to discover and develop effective treatments for cognition in MS. By recognizing the relative strengths and weaknesses of strategy and functional training, we will be best positioned to benefit from an approach that combines both.
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